356 related articles for article (PubMed ID: 31915250)
1. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
2. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
3. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
4. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
[TBL] [Abstract][Full Text] [Related]
5. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia.
Liu J; Pang Y; Chang T; Bounelis P; Chatham JC; Marchase RB
J Mol Cell Cardiol; 2006 Feb; 40(2):303-12. PubMed ID: 16337959
[TBL] [Abstract][Full Text] [Related]
6. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
7. The Hexosamine Biosynthesis Pathway: Regulation and Function.
Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
[TBL] [Abstract][Full Text] [Related]
8. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.
Liu J; Marchase RB; Chatham JC
J Mol Cell Cardiol; 2007 Jan; 42(1):177-85. PubMed ID: 17069847
[TBL] [Abstract][Full Text] [Related]
9. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
Marsh SA; Dell'Italia LJ; Chatham JC
Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
[TBL] [Abstract][Full Text] [Related]
10. Temporal regulation of protein O-GlcNAc levels during pressure-overload cardiac hypertrophy.
Zhu WZ; Ledee D; Olson AK
Physiol Rep; 2021 Aug; 9(15):e14965. PubMed ID: 34337900
[TBL] [Abstract][Full Text] [Related]
11. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Phillips RM; Lam C; Wang H; Tran PT
Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
[TBL] [Abstract][Full Text] [Related]
12. Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine.
Nagy T; Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C57-65. PubMed ID: 16107505
[TBL] [Abstract][Full Text] [Related]
13. The hexosamine biosynthesis pathway and O-GlcNAcylation maintain insulin-stimulated PI3K-PKB phosphorylation and tumour cell growth after short-term glucose deprivation.
Jones DR; Keune WJ; Anderson KE; Stephens LR; Hawkins PT; Divecha N
FEBS J; 2014 Aug; 281(16):3591-608. PubMed ID: 24938479
[TBL] [Abstract][Full Text] [Related]
14. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
[TBL] [Abstract][Full Text] [Related]
15. Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels.
Marshall S; Nadeau O; Yamasaki K
J Biol Chem; 2004 Aug; 279(34):35313-9. PubMed ID: 15199059
[TBL] [Abstract][Full Text] [Related]
16. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
17. Nutrient shortage triggers the hexosamine biosynthetic pathway via the GCN2-ATF4 signalling pathway.
Chaveroux C; Sarcinelli C; Barbet V; Belfeki S; Barthelaix A; Ferraro-Peyret C; Lebecque S; Renno T; Bruhat A; Fafournoux P; Manié SN
Sci Rep; 2016 Jun; 6():27278. PubMed ID: 27255611
[TBL] [Abstract][Full Text] [Related]
18. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.
Fülöp N; Marchase RB; Chatham JC
Cardiovasc Res; 2007 Jan; 73(2):288-97. PubMed ID: 16970929
[TBL] [Abstract][Full Text] [Related]
19. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH
Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
Itano N; Iwamoto S
Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]